AI tools to predict and guide prostate cancer care
Part of Cancer, Kidney & urinary clinical trials.
This study uses artificial intelligence to help doctors predict the best treatment for prostate cancer. It may help match you with the most effective care based on your specific situation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a suspected prostate cancer diagnosis, such as an elevated PSA test or suspicious findings on an ultrasound or MRI.
- You have not had any prior prostate cancer treatment, including surgery, radiation, chemotherapy, hormone therapy, targeted therapy, or immunotherapy.
- You have complete medical records and test results available.
- You have no other current cancers or serious health conditions that could interfere with the study.
- You are able to provide informed consent and are willing to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses artificial intelligence to examine MRI and other health data to better predict if high-risk prostate cancer has spread to nearby lymph nodes. Researchers hope this will help guide treatment decisions.
This study tests an artificial intelligence (AI) tool that may improve how doctors detect prostate cancer using imaging and biopsy information. It could help better identify cancer that is suspected based on PSA blood tests and rectal exam findings.
This trial tests whether an AI program can better spot aggressive prostate cancer on MRI scans, which may help guide treatment decisions. Participation involves having an MRI and possibly a biopsy, and your scan will be analyzed by the software.
This study uses artificial intelligence to look at your MRI scans, tissue samples, and medical records to learn more about prostate cancer and find better ways to treat it. You may join if you've had prostate removal surgery or have advanced prostate cancer.
This trial studies how AI might improve the process of prostate biopsies for people who have had an MRI. It may help if you are scheduled for a biopsy and have not been treated for prostate cancer before.
This trial is testing an artificial intelligence (AI) system that helps doctors diagnose and treat urological conditions like urinary stones, prostate cancer, or bladder cancer. It looks at your medical records, scans, and surgical videos to improve care.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.